Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis.

Slides:



Advertisements
Similar presentations
Date of download: 5/28/2016 From: When to Start Antiretroviral Therapy in Resource-Limited Settings Ann Intern Med. 2009;151(3): doi: /
Advertisements

Date of download: 5/29/2016 From: A Cost Analysis of Alternative Treatments for Duodenal Ulcer Ann Intern Med. 1995;123(9): doi: /
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.
Date of download: 5/31/2016 From: Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age Ann Intern Med. 2008;148(12): doi: /
Date of download: 5/31/2016 From: Benefits, Harms, and Cost-Effectiveness of Supplemental Ultrasonography Screening for Women With Dense Breasts Ann Intern.
Date of download: 6/1/2016 From: Cost-Effectiveness of Radiofrequency Ablation for Supraventricular Tachycardia Ann Intern Med. 2000;133(11): doi: /
Date of download: 6/1/2016 From: Cost-Effectiveness of Novel Regimens for the Treatment of Hepatitis C Virus Ann Intern Med. 2015;162(6): doi: /M
Date of download: 6/1/2016 From: Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms.
Date of download: 6/1/2016 From: Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules Ann Intern Med. 2003;138(9):
Date of download: 6/2/2016 From: New Protease Inhibitors for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Ann Intern Med. 2012;156(4):
Date of download: 6/2/2016 From: Quantitative Synthesis in Systematic Reviews Ann Intern Med. 1997;127(9): doi: /
Date of download: 6/3/2016 From: Mortality Rates in Elderly Patients Who Take Different Angiotensin-Converting Enzyme Inhibitors after Acute Myocardial.
Date of download: 6/3/2016 From: Chest Pain Relief by Nitroglycerin Does Not Predict Active Coronary Artery Disease Ann Intern Med. 2003;139(12):
Date of download: 6/3/2016 From: Sex, Age, and Birth Cohort Effects in Colorectal Neoplasms: A Cohort Analysis Ann Intern Med. 2010;152(11): doi: /
Date of download: 6/3/2016 From: Surgery Versus Nonsurgical Treatment of Lumbar Spinal Stenosis: A Randomized Trial Ann Intern Med. 2015;162(7):
Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.
Date of download: 6/3/2016 From: Cost-Effectiveness of Treatment of Diabetic Macular Edema Ann Intern Med. 2014;160(1): doi: /M Markov.
Date of download: 6/3/2016 From: Radial Versus Femoral Access in Invasively Managed Patients With Acute Coronary Syndrome: A Systematic Review and Meta-analysis.
Date of download: 6/9/2016 From: Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes Ann Intern Med.
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Date of download: 6/21/2016 From: Aspirin for the Primary Prevention of Cardiovascular Events: A Systematic Evidence Review for the U.S. Preventive Services.
Date of download: 6/22/2016 From: The Efficacy of Influenza Vaccine in Elderly Persons: A Meta-Analysis and Review of the Literature Ann Intern Med. 1995;123(7):
Date of download: 6/23/2016 From: Relative Effectiveness of Osteoporosis Drugs for Preventing Nonvertebral Fracture Ann Intern Med. 2008;148(9):
Date of download: 6/24/2016 From: Effectiveness of Manual Physical Therapy and Exercise in Osteoarthritis of the Knee: A Randomized, Controlled Trial Ann.
Date of download: 6/25/2016 From: Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic.
Date of download: 6/25/2016 From: Cost-Effectiveness of the Children's Oncology Group Long-Term Follow-up Screening Guidelines for Childhood Cancer Survivors.
Date of download: 6/26/2016 From: Lipid-Lowering Therapy in Persons With Chronic Kidney Disease: A Systematic Review and Meta- analysis Ann Intern Med.
Date of download: 6/26/2016 From: Aspirin for the Prevention of Cancer Incidence and Mortality: Systematic Evidence Reviews for the U.S. Preventive Services.
Date of download: 6/26/2016 From: Cost-Effectiveness of Adding Cardiac Resynchronization Therapy to an Implantable Cardioverter- Defibrillator Among Patients.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Cost-Effectiveness of C-Reactive Protein Testing.
Date of download: 6/26/2016 From: Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in.
Date of download: 6/27/2016 From: Influence of Alternative Thresholds for Initiating HIV Treatment on Quality-Adjusted Life Expectancy: A Decision Model.
Date of download: 6/27/2016 From: Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease: A Cost- Effectiveness Analysis.
Date of download: 6/27/2016 From: Should Colorectal Cancer Screening Be Considered in Elderly Persons Without Previous Screening?: A Cost-Effectiveness.
Date of download: 6/28/2016 From: Drug Treatment of Hypertension in the Elderly: A Meta-Analysis Ann Intern Med. 1994;121(5): doi: /
Date of download: 6/29/2016 From: Inviting Patients to Read Their Doctors' Notes: A Quasi-experimental Study and a Look Ahead Ann Intern Med. 2012;157(7):
Date of download: 7/1/2016 From: Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task.
Date of download: 7/7/2016 From: Management of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American.
Date of download: 7/9/2016 From: Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac.
Date of download: 7/10/2016 From: Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial.
Date of download: 7/11/2016 From: Cost-Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease Ann Intern Med. 2013;159(6):
Date of download: 9/16/2016 From: Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report.
Date of download: 9/17/2016 From: Behavioral Therapy to Enable Women with Urge Incontinence to Discontinue Drug Treatment: A Randomized Trial Ann Intern.
Date of download: 9/17/2016 From: Topical Treatment of Pressure Ulcers with Nerve Growth Factor: A Randomized Clinical Trial Ann Intern Med. 2003;139(8):
Date of download: 9/18/2016 From: Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary.
Date of download: 9/18/2016 From: Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal Ann Intern Med. 2013;158(1):1-9.
Date of download: 9/19/2016 From: The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care Ann.
Date of download: 9/19/2016 From: Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use: A Nationwide.
From: Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study Ann Intern Med. 2015;163(5):
From: Screening for Syphilis Infection in Pregnancy: U. S
From: Benefits and Harms of Statin Therapy for Persons With Chronic Kidney DiseaseA Systematic Review and Meta-analysis Ann Intern Med. 2012;157(4):
Copyright © 2012 American Medical Association. All rights reserved.
From: Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 DiabetesA Systematic Review and Meta-analysis Ann Intern Med.
From: The Implications of Regional Variations in Medicare Spending
From: Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic AgentsA Cost-Effectiveness.
Copyright © 2011 American Medical Association. All rights reserved.
Ann Intern Med. 2000;133(6): doi: / Figure Legend:
From: An Externally Validated Model for Predicting Long-Term Survival after Exercise Treadmill Testing in Patients with Suspected Coronary Artery Disease.
From: Systematic Review: Strategies for Using Exercise Therapy To Improve Outcomes in Chronic Low Back Pain Ann Intern Med. 2005;142(9): doi: /
Copyright © 2000 American Medical Association. All rights reserved.
From: The Evolving Diabetes Burden in the United States
Copyright © 2004 American Medical Association. All rights reserved.
From: The In-Training Examination in Internal Medicine: An Analysis of Resident Performance over Time Ann Intern Med. 2002;137(6): doi: /
Markov model structure
Ann Intern Med. 2009;150(11): doi: / Figure Legend:
From: Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
Copyright © 2007 American Medical Association. All rights reserved.
From: Treatment of Blood Cholesterol to Reduce Risk for Atherosclerotic Cardiovascular DiseaseGrand Rounds Discussion From the Beth Israel Deaconess Medical.
On Statin Treatment to Prevent Sepsis in Dialysis Patients
Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost- effectiveness analysis  Mark D. Schleinitz, MS, MD, J.Peter Weiss, MS,
Presentation transcript:

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / General structure of the Markov model.Patients enter the model while taking their specified therapy and can progress from healthy to other states, including death, in each cycle. Patients who have aspirin-related gastrointestinal bleeding or statin-related myopathy stop taking the offending medication. Hemorrhagic stroke is modeled separately in the alternate scenario only. MI = myocardial infarction. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Effect of annual statin cost on cost-effectiveness for the combination of aspirin and a statin versus aspirin alone.Statin cost is expressed in 2003 dollars. Base-case value is shown with the dotted vertical line. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Effect of the annual excess risk for gastrointestinal bleeding with aspirin on the cost–utility ratio for aspirin versus no treatment.Base-case value is shown with the dotted vertical line. Cost–utility ratios below $0 per quality-adjusted life-year represent the range over which aspirin is more effective and less costly. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Results of probabilistic sensitivity analysis for men with a 10-year risk for CHD of 7.5% (base case): aspirin versus no treatment.Plot of incremental costs versus incremental quality-adjusted life-years for aspirin versus no treatment; the diagonal line represents the incremental cost-effectiveness ratio of $ Individual dots represent results for each of 1000 iterations of the model; quadrant 1 contains 1.80% of iterations, quadrant 2 contains 0.00%, quadrant 3 contains 7.20%, and quadrant 4 contains 91.00%. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Results of probabilistic sensitivity analysis for men with a 10-year risk for CHD of 2.5%: aspirin versus no treatment.Top.Bottom. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Results of probabilistic sensitivity analysis for men with a 10-year risk for CHD of 5%: aspirin versus no treatment.Top.Bottom. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Results of probabilistic sensitivity analysis for men with a 10-year risk for CHD of 10%: aspirin versus no treatment. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Results of probabilistic sensitivity analysis for men with a 10-year risk for CHD of 15%: aspirin versus no treatment. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Results of probabilistic sensitivity analysis for men with a 10-year risk for CHD of 25%: aspirin versus no treatment. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Results of probabilistic sensitivity analysis for men with a 10-year risk for CHD of 10%: aspirin plus statin versus aspirin alone.Top.Bottom. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Date of download: 6/21/2016 From: Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis Ann Intern Med. 2006;144(5): doi: / Results of probabilistic sensitivity analysis for men with a 10-year risk for CHD of 15%: aspirin plus statin versus aspirin alone.Top.Bottom. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.